Vertex Pharmaceuticals today announced that the New Zealand Medicines and Medical Devices Safety Authority (Medsafe) has granted consent for the expanded use of TRIKAFTA® ...

A new study from The Hospital for Sick Children (SickKids) reveals the process underlying protein organization on cell ...

In March 2025, Vertex Pharmaceuticals Incorporated announced a study is to evaluate the safety, and tolerability and efficacy ...

Those who already own VRTX stock may retain it for some time to see if its CF sales continue to rise and how the Journavx and ...

The Hospital for Sick Children. "Newly uncovered mechanism could drive next-gen cystic fibrosis treatments." ScienceDaily. ScienceDaily, 13 March 2025. <www.sciencedaily.com / releases / 2025 / 03 / ...

A new research project focusing on rare genetic mutations that are linked to cystic fibrosis just received $600,000 in ...

Studying how proteins cluster and organize themselves at the cell membrane could pave the way for innovative cystic fibrosis ...

Cystic fibrosis (CF) patients could be given access to a new drug on the NHS by the end of the year if it is given the green ...

暴饮暴食后的“沉默杀手”：急性胰腺炎的三大诱因广西中医药大学第一附属医院仙葫院区刘慧莲急性胰腺炎是胰腺组织因胰酶异常激活而发生的自身消化性炎症，具有起病急、进展快、致死率高的特点。

A new study from The Hospital for Sick Children (SickKids) reveals the process underlying protein organization on cell membranes, a finding which ...

A MIRACLE pill that’s been shown to help with many of the symptoms of cystic fibrosis (CF) has been approved for thousands of ...

The company also develops CASGEVY for the treatment of sickle cell disease and transfusion-dependent beta thalassemia; JOURNAVX for the treatment of acute pain in adults; VX-522, a CFTR mRNA ...